Position in QGEN
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$235,421
-$104,327 QoQ
Shares Held
6,021
-20.3% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#228
of 332 holders
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in QGEN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026North Dakota State Investment Board holds $22,195,196 across 16 Diagnostics & Research names. QGEN ranks #16 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
10,961 | $5,495,406 | |
| 2 | ILMN |
Illumina, Inc.
|
20,448 | $3,595,371 | |
| 3 | DHR |
Danaher Corp /De/
|
18,724 | $3,566,547 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
2,369 | $1,247,136 | |
| 5 | A |
Agilent Technologies, Inc.
|
8,473 | $1,125,468 | |
| 6 | WAT |
Waters Corp /De/
|
2,922 | $1,095,866 | |
| 7 | NTRA |
Natera, Inc.
|
3,928 | $1,066,255 | |
| 8 | IQV |
Iqvia Holdings Inc.
|
5,023 | $970,544 |
All Filings in QGEN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $235,421 | 6,021 | Shares | Sole | 2026-08-04 | |
| 2025-12-31 | $339,748 | 7,555 | Shares | Sole | 2026-02-05 | |
| No filing history on record for this holder in this stock. | ||||||